Publicaciones en colaboración con investigadores/as de Hospital Xàtiva Lluis Alcanyis (12)

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum

    Clinical journal of the American Society of Nephrology : CJASN

  3. Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 5, pp. 994-999

2021

  1. Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2

    International Journal of Cardiology, Vol. 330, pp. 268-272

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

  2. Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)

    Epilepsy Research

2016

  1. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

    Epilepsy Research, Vol. 126, pp. 201-210

2015

  1. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131

2006

  1. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: A cross-sectional study

    Cardiovascular Diabetology, Vol. 5

2005

  1. Control of hypertension in patients at high risk of cardiovascular disease

    QJM - Monthly Journal of the Association of Physicians, Vol. 98, Núm. 8, pp. 581-588

2001

  1. Risk and prognostic factors of Pseudomonas aeruginosa bacteremia in critically ill patients

    Medicina Clinica, Vol. 117, Núm. 19, pp. 721-726